Alemtuzumab Intravenous and Dextenza intraocular
Determining the interaction of Alemtuzumab Intravenous and Dextenza intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Dextran 40
- Alemtuzumab Intravenous-Dextran 70 6% in 5% Dextrose high molecular weight
- Alemtuzumab Intravenous-Dextran 75
- Alemtuzumab Intravenous-Dextran high molecular weight
- Alemtuzumab Intravenous-Dextranomer and Hyaluronate Derivatives (Deflux)
- Alemtuzumab Intravenous-Dextranomer and Hyaluronate Derivatives (Solesta)
- Dextenza intraocular-Alenaze-D
- Dextenza intraocular-Alendronate
- Dextenza intraocular-Alendronate and cholecalciferol
- Dextenza intraocular-Alendronate Effervescent Tablets
- Dextenza intraocular-Alendronate Oral Solution
- Dextenza intraocular-Alendronate Sodium